Moore Capital Management’s Alnylam Pharmaceuticals ALNY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-4,635
| Closed | -$887K | – | 387 |
|
|
2023
Q4 | $887K | Sell |
4,635
-17,350
| -79% | -$3.32M | 0.02% | 254 |
|
|
2023
Q3 | $3.89M | Buy |
+21,985
| New | +$3.89M | 0.07% | 153 |
|
|
2023
Q1 | – | Sell |
-10,000
| Closed | -$2.38M | – | 463 |
|
|
2022
Q4 | $2.38M | Sell |
10,000
-11,247
| -53% | -$2.67M | 0.06% | 237 |
|
|
2022
Q3 | $4.25M | Buy |
+21,247
| New | +$4.25M | 0.1% | 211 |
|
|
2015
Q2 | – | Sell |
-5,500
| Closed | -$574K | – | 355 |
|
|
2015
Q1 | $574K | Buy |
+5,500
| New | +$574K | 0.01% | 315 |
|